Profile
Andrew Marsh worked as the Head of Clinical Development at Ra Pharmaceuticals, Inc. and later as the Head of Development Operations at Synlogic, Inc. He completed his undergraduate degree at Boston University.
Former positions of Andrew Marsh
| Companies | Position | End |
|---|---|---|
| SYNLOGIC, INC. | Corporate Officer/Principal | 01/05/2021 |
| RA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Training of Andrew Marsh
| Boston University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SYNLOGIC, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Ra Pharmaceuticals, Inc.
 Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Andrew Marsh
